Tavolara et al. used an AB-MIL model to automate the quantification of c-MYC and BCL2 IHC expression, which correlated with pathologist assessments and improved prognostic stratification of double-expressor DLBCL, a subtype of DLBCL [19]. Here, BCL2 is linked to diffuse large B-cell lymphoma.